# Developmental Funds

> **NIH NIH P30** · MAYO CLINIC ROCHESTER · 2021 · $447,041

## Abstract

DEVELOPMENTAL FUNDS PROJECT SUMMARY 
The Mayo Clinic Cancer Center (MCCC) considers Developmental Funds to be one of the most critical 
components of Cancer Center Support Grant (CCSG) support. Together with institutionally derived MCCC 
discretionary funds and philanthropic support, these funds have supported the recruitment of new research 
faculty, development of Shared Resources, pilot projects to generate preliminary data in support of peer- 
reviewed funding opportunities, and support for Staff Investigators. Processes are firmly established in the 
MCCC to solicit and review proposals for CCSG Developmental Fund support. Funding is predicated on 
scientific merit, programmatic relevance, MCCC strategic priorities and, in the case of Shared Resource 
development, the unambiguous needs of MCCC members with peer-reviewed funding. We are requesting 
increased funding in the next project period to support initiatives in the following categories: 
 • Recruitment of outstanding new research faculty. In the past funding cycle, CCSG Developmental 
 Funds were used to support the recruitment of 2 outstanding faculty members. We are requesting 
 support to recruit 3 junior faculty each year over the 5 years of the next grant cycle, with support for 
 recruitment of senior faculty provided by the institution and philanthropy. 
 • Development of new Shared Resources and new technologies and services to ensure the 
 scientific vitality of MCCC members and Programs. Development of one new Shared Resource 
 (Immune Monitoring) is underway, and a second (Organoid) is being investigated. 
 • Pilot projects. MCCC has used Developmental Funds to support highly innovative but high-risk 
 proposals both within the Cancer Center and in conjunction with outside institutions, and will continue to 
 do so in the next cycle. 
 • Staff Investigators. As in the past funding cycle, we are requesting funds to provide partial salary 
 support for 3 Staff Investigators in Basic Science (genomics), Clinical and Translational Research 
 (immuno-oncology), and Population Sciences (prevention and screening).

## Key facts

- **NIH application ID:** 10113623
- **Project number:** 5P30CA015083-47
- **Recipient organization:** MAYO CLINIC ROCHESTER
- **Principal Investigator:** Rafael Fonseca
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $447,041
- **Award type:** 5
- **Project period:** 1997-04-25 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10113623

## Citation

> US National Institutes of Health, RePORTER application 10113623, Developmental Funds (5P30CA015083-47). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10113623. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*